Cargando…
Developmental Comparison of Ceramide in Wild-Type and Cln3(Δex7/8) Mouse Brains and Sera
CLN3 disease is a neurodevelopmental disease leading to early visual failure, motor decline, and death. CLN3 pathogenesis has been linked to dysregulation of ceramide, a key intracellular messenger impacting various biological functions. Ceramide is upregulated in brains of CLN3 patients and activat...
Autores principales: | El-Sitt, Sally, Soueid, Jihane, Al Ali, Jamal, Makoukji, Joelle, Makhoul, Nadine J., Harati, Hayat, Boustany, Rose-Mary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389635/ https://www.ncbi.nlm.nih.gov/pubmed/30837943 http://dx.doi.org/10.3389/fneur.2019.00128 |
Ejemplares similares
-
Sex differences in gene expression with galactosylceramide treatment in Cln3(Δex7/8) mice
por: Makoukji, Joelle, et al.
Publicado: (2020) -
Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer Patients
por: Makoukji, Joelle, et al.
Publicado: (2015) -
Exogenous Flupirtine as Potential Treatment for CLN3 Disease
por: Maalouf, Katia, et al.
Publicado: (2020) -
RYR2, PTDSS1 and AREG genes are implicated in a Lebanese population-based study of copy number variation in autism
por: Soueid, Jihane, et al.
Publicado: (2016) -
Glycerophosphoinositol is Elevated in Blood Samples From
CLN3(Δex7-8) pigs,
Cln3(Δex7-8) Mice, and CLN3-Affected
Individuals
por: Brudvig, Jon J, et al.
Publicado: (2022)